Für statistische Zwecke und um bestmögliche Funktionalität zu bieten, speichert diese Website Cookies auf Ihrem Gerät. Das Speichern von Cookies kann in den Browser-Einstellungen deaktiviert werden. Wenn Sie die Website weiter nutzen, stimmen Sie der Verwendung von Cookies zu.

Cookie akzeptieren
Swiss Reinsurance Company / M. L. Hefti et al (Hrsg.). Annals of Life Insurance Medicine 6 - Proceedings of the 13th International Congress of Life Assurance Medicine Madrid 1979. Springer Berlin Heidelberg, 2011.

Annals of Life Insurance Medicine 6

Proceedings of the 13th International Congress of Life Assurance Medicine Madrid 1979
  • Springer Berlin Heidelberg
  • 2011
  • Taschenbuch
  • 280 Seiten
  • ISBN 9783642676314
Herausgeber: Swiss Reinsurance Company / M. L. Hefti / E. Tanner

Today, the integration of life insurance medicine into the framework of general medicine goes without saying. On the one hand, the diagnostic therapeutic knowledge of clinical medical science forms the tools of the insurance medical adviser for the evaluation of life insurance applications. On the other hand, life insurance medicine has been able to pro­ vide valuable statistical data for long-term prognosis which have become an essential part of the daily medical practice and prognostic appraisal. This mutual engagement and en­ richment has again distinctly manifested itself in the scientific program of the 13th Con­ gress of Life Assurance Medicine held in Madrid. Among the broad

Mehr Weniger
and varied data available, the insurance problem of cancer and ma­ lignant diseases of the haematopoietic system were extensively dealt with for the first time. Diagnostic therapeutic progress increasingly allows valuable insurance cover to be granted to formerly uninsurable risks, a group which is particularly in need of, and re­ quires, life insurance cover. The number of risks which are uninsurable becomes smaller and smaller.

in Kürze